What is Ustekinumab?

Category: Prescription Drugs

Most popular types: Stelara

false

Ustekinumab is an antipsoriatic agent, monoclonal antibody. It is used in the treatment of moderate to severe plaque psoriasis.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Psoriasis 45 38
Psoriatic arthritis 14 4
Crohn's disease 4 3
Pyoderma gangrenosum 1 0

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
0
Moderate
0
Mild
9
None
31

Commonly reported side effects and conditions associated with Ustekinumab

Side effect Patients
Headaches 3
Achiness 1
Bronchiectasis 1
Excessive dry mouth 1
Fatigue 1
Immune system weak 1

Show all 9 reported side effects

Dosages

Based on patients currently taking Ustekinumab

Dosage Patients
90 mg every 12 weeks 2
1 mg every 3 months 1
1 other monthly 1
3 mg every 3 months 1
45 mg every 3 months 1
90 mg every 3 months 1
90 mg every 8 weeks 1

Why patients stopped taking Ustekinumab

Multiple reasons could be selected

Reason Patients
Did not seem to work 8
Other 3
Course of treatment ended 2
Doctor's advice 2
Change in health plan coverage 1
Side effects too severe 1
See all 12 patients who've stopped taking Ustekinumab

Duration

Currently taking Ustekinumab

Duration Patients
1 - 2 years 3
2 - 5 years 4
5 - 10 years 1

Stopped taking Ustekinumab

Duration Patients
1 - 6 months 5
6 months - 1 year 6
2 - 5 years 1
Adherence
Adherence Evaluations
Always 39
Usually 1
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 2
A little hard to take 5
Not at all hard to take 33
Cost per month
Cost per month Evaluations
$200+ 4
$100-199 0
$50-99 6
$25-49 2
< $25 22
Not specified 6

What people switch to and from

Patients started taking Ustekinumab after stopping:

Treatment Patients
Adalimumab (Humira) 5
Etanercept (Enbrel SureClick) 4
Clobetasol topical (Clobex) 1
Hydrocortisone topical (Cortizone-10) 1
Infliximab (Remicade) 1

Patients stopped taking Ustekinumab and switched to:

Treatment Patients
Secukinumab (Cosentyx) 2
Ixekizumab (Taltz) 1
Last updated:
There are no evaluations for Ustekinumab.